Loading data for NAUT — first visit, this takes a few seconds.

Nautilus Biotechnology In...

NasdaqCM: NAUT · Real-Time Price · USD
0.88
-0.07 (-7.37%)
At close: Aug 25, 2026, 8:00 PM
0.90
+2.12%
After-hours: 7:57 PM

The price, the headline numbers and the latest news, in one place.

Nautilus Biotechnology Inc. (NAUT) Stock Price, Analysis & Data

-7.37%

No data available

Bid0.67
Market Cap112.15M
Revenue (ttm)190K
Net Income (ttm)-56.52M
0.87
-0.45
n/a
-1.19
P/B (ttm)0.85
P/S (ttm)589.45
Earnings DateOct 27, 2026
Ask1.18
Volume605,118
Avg. Volume (20D)851,076
Open0.97
Previous Close0.95
Day's Range0.86 - 0.98
52-Week Range0.62 - 4.31
Analystn/a
Price Targetn/a
Dividendsn/a
Ex-Dividend Daten/a

About NAUT

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with inte...

Industry Biotechnology
Sector Healthcare
IPO Date Aug 7, 2020
Employees 127
Stock Exchange NasdaqCM
Ticker Symbol NAUT
Full Company Profile

Financial Performance

In 2025, Nautilus Biotechnology's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -59M, a decrease of -16.64%.

Financial Statements

Earnings Surprise

Nautilus Biotechnology has released their quarterly earnings on Jul 28, 2026:
  • Revenue of $10K misses estimates by $0, with Infinity% YoY growth.
  • EPS of -0.11 exceeds estimates by 0.03, with 8.33% YoY growth.
Nautilus Biotechnology Inc. is scheduled to release its earnings on Oct 27, 2026, before market opens.
Analysts project revenue of ... Upgrade